The North American region is expected to contribute higher in the global defibrillator market with major revenue generation from the U.S. region. The growth is attributed to the increasing number of aged populations. According to WHO,the incidence and prevalence rate of heart attacks are highest in North America, which is responsible for 0.7 million fatalities each year. According to Heart & Stroke Foundation in Canada alone, 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease.
Further, Automated external defibrillator (AED)are widely adopted procedures in the defibrillator market and have a considerable market share. Growing CVD, CHD, stroke and other heart diseases, highest healthcare spending, technological advancement and adoption of hybrid operating rooms and minimally invasive surgeries are the key drivers of the North American Market. However, providing heart stroke related services in urban and rural regions is still a challenge to North America owing to huge demand.
To Request a Sample of our Report on North American Defibrillators Market: https://www.omrglobal.com/request-sample/north-american-defibrillators-market
The North American defibrillator market is growing significantly across the globe due to rising heart patients, FDA approvals, growing adoption of minimally invasive/non-invasive surgeries and technological advancement in the defibrillator market. Due to huge adoption of AED and technical advancement in the defibrillation technology, and North America having the highest number of patients with heart diseases,giving rise to the adoption of robotic automation in the AED. North America has a considerable market share for capacitor, inductor and power supply market segment. Adoption of innovative technologies are boosting the market growth. Further, the presence of the key players also contributes to the growth of the market during the forecast period.
The only commercially available wearable defibrillator to date is the LifeVest, manufactured by ZOLL Medical Corporation and approved by the US FDA in 2002. It consists of an elastic belt and shoulder strap that carries four dry, non-adhesive sensing electrodes and three defibrillator electrodes. The electrodes exude gels automatically just before the delivery of a shock. The US FDA classifies medical devices into three class that is Class I, Class II and Class III. Most of the defibrillators are placed under Class II or Class III category by the US FDA.
(Get 15% Discount on Buying this Report)
A full Report of North American Defibrillators Market is Available @ https://www.omrglobal.com/industry-reports/north-american-defibrillators-market
North American Defibrillators Market Segmentation
By Type
- Implantable Cardioverter Defibrillators
- External Cardioverter Defibrillators
By End-Users
- Hospitals
- Ambulatory Services and Others
Regional Analysis
- United States
- Canada
Company Profiles
- Abbott Laboratories, Inc.
- Biotronik SE & Co. KG
- Cintas Corp.
- Defibtech, LLC
- General Electric Co.
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic PLC
- Mindray Medical International Co. Ltd.
- Nihon Kohden Corp.
- Stryker Corp.
- ZOLL Medical Corp. (an Asahi Kasei Group company)
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
